• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Obstet Gynaecol Can . Obstetrical and Newborn Outcomes among Patients with SARS-CoV-2 during Pregnancy

tetano

Editor, Senior Moderator
J Obstet Gynaecol Can


. 2021 Mar 27;S1701-2163(21)00298-X.
doi: 10.1016/j.jogc.2021.03.012. Online ahead of print.
Obstetrical and Newborn Outcomes among Patients with SARS-CoV-2 during Pregnancy


Marie-Julie Trahan[SUP] 1 [/SUP], Isabelle Malham?[SUP] 2 [/SUP], Patrick O'Farrell[SUP] 1 [/SUP], Cristina Mitric[SUP] 1 [/SUP], Jade Desilets[SUP] 1 [/SUP], Marie-Pier Bastrash[SUP] 1 [/SUP], Amira El-Messidi[SUP] 3 [/SUP], Haim A Abenhaim[SUP] 4 [/SUP]



Affiliations

Abstract

We report on the perinatal outcomes of pregnant patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from 2 hospitals in Montr?al, Qu?bec. Outcomes of 45 patients with SARS-CoV-2 during pregnancy were compared with those of 225 patients without infection. Sixteen percent of patients with SARS-CoV-2 delivered preterm, compared with 9% of patients without (P = 0.28). Median gestational age at delivery (39.3 (interquartile range [IQR] 37.7-40.4) wk vs. 39.1 [IQR 38.3-40.1] wk) and median birthweight (3250 [IQR 2780-3530] g vs. 3340 [IQR 3025-3665] g) were similar between groups. The rate of cesarean delivery was 29% for patients with SARS-CoV-2. Therefore, we did not find important differences in outcomes associated with SARS-CoV-2. Our findings may be limited to women with mild COVID-19 diagnosed in the third trimester.

Keywords: COVID-19; cesarean delivery; coronavirus; outcomes; pregnancy; preterm delivery.




Marie-Julie Trahan[SUP] 1 [/SUP], Isabelle Malham?[SUP] 2 [/SUP], Patrick O'Farrell[SUP] 1 [/SUP], Cristina Mitric[SUP] 1 [/SUP], Jade Desilets[SUP] 1 [/SUP], Marie-Pier Bastrash[SUP] 1 [/SUP], Amira El-Messidi[SUP] 3 [/SUP], Haim A Abenhaim[SUP] 4 [/SUP]



Affiliations

Abstract

We report on the perinatal outcomes of pregnant patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from 2 hospitals in Montr?al, Qu?bec. Outcomes of 45 patients with SARS-CoV-2 during pregnancy were compared with those of 225 patients without infection. Sixteen percent of patients with SARS-CoV-2 delivered preterm, compared with 9% of patients without (P = 0.28). Median gestational age at delivery (39.3 (interquartile range [IQR] 37.7-40.4) wk vs. 39.1 [IQR 38.3-40.1] wk) and median birthweight (3250 [IQR 2780-3530] g vs. 3340 [IQR 3025-3665] g) were similar between groups. The rate of cesarean delivery was 29% for patients with SARS-CoV-2. Therefore, we did not find important differences in outcomes associated with SARS-CoV-2. Our findings may be limited to women with mild COVID-19 diagnosed in the third trimester.

Keywords: COVID-19; cesarean delivery; coronavirus; outcomes; pregnancy; preterm delivery.
 
Back
Top Bottom